Description
Cabozanix, a potent multiple Tyrosine Kinase inhibitor, is specifically designated for the therapeutic management of Renal Cell Carcinoma (RCC) and Metastatic Thyroid Cancer.
Cabozanix, a potent multiple Tyrosine Kinase inhibitor, is specifically designated for the therapeutic management of Renal Cell Carcinoma (RCC) and Metastatic Thyroid Cancer.